Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 883984 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $168.38Day +1.11%Mkt cap $4.2BP/E (FY) 5612.7×1Y +34.2%Off 52W high −1.4%Vol (1Y) 38.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,294 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesNEVER-OBSERVED · 39.3% growth |
| Short interest7.3% of sh out |
| Days to cover6.7d |
| 13F net flow (QoQ)−6.54% |
| Top-10 13F concentration55.9% |
| Next report (est.)2026-08-06 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)5612.7× |
| Sales (TTM)$2.16B |
| Earnings (TTM)$46.3M |
| ROE0.0% |
| Net margin0.0% |
| Debt / equity0.60× |
| YTD+18.0% |
| 1Y+34.2% |
| 3Y−5.5% |
| 5Y−17.2% |
| 10Y+43.8% |
| Since incept. (ann.)+8.1% |
Total return through 2026-07-30 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)38.6% |
| Ann. volatility (3Y)43.1% |
| Sharpe (1Y)0.94 |
| Sharpe (3Y)0.17 |
| Max drawdown (1Y)−27.2% |
| Max drawdown (3Y)−54.5% |
| Beta (3Y vs SPY)0.91 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 3.6M | $466M | 14.61% | +0.6% |
| JANUS HENDERSON GROUP PLC | 2.7M | $346M | 10.84% | +3.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.4M | $186M | 5.82% | new |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.2M | $158M | 4.94% | −51.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $144M | 4.50% | new |
| DIMENSIONAL FUND ADVISORS LP | 983,802 | $127M | 3.98% | +6.8% |
| STATE STREET CORP | 968,053 | $125M | 3.92% | +2.7% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 701,280 | $88M | 2.84% | −8.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 101.3% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 1,628,295 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | $1.20 | — | $530.2M | −12.3% |
| 2025-12-31 | 2026-02-19 | — | — | $540.7M | −14.1% |
| 2025-09-30 | 2025-11-06 | −$0.14 | — | $537.0M | −8.9% |
| 2025-06-30 | 2025-08-07 | $1.43 | — | $548.9M | −8.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
US 61% · EMEA 18% · APACDomain 10% · Otherforeigncountries 10%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Total debt / EBITDA5.27× |
| Sales growth 3Y−0.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
